Literature DB >> 25857296

Association of advanced age with concentrations of uraemic toxins in CKD.

Merita Rroji1, Sunny Eloot2, Annemie Dhondt3, Wim Van Biesen3, Griet Glorieux3, Nathalie Neirynck3, Nele Vandennoortgate4, Sophie Liabeuf5,6, Ziad Massy5,7, Raymond Vanholder3.   

Abstract

To our knowledge, there are no studies on advanced chronic kidney disease (CKD) analysing the impact of ageing on serum concentrations of uraemic toxins while adjusting for renal function. Knowledge of this feature, however, could influence prognostic assessment and therapeutic decision-making, e.g. about when to start dialysis or how intensive it should be. Indeed, the slowing down of metabolism with age may result in lower uraemic toxin concentrations, hence reducing their toxic effects. In this case, a later start of dialysis or less intensive dialysis may become justified in an already fragile population that might enjoy a better quality of life without a survival disadvantage with conservative treatment. We assessed the impact of advancing age on uraemic solute concentrations [blood, urea, nitrogen (BUN), uric acid, creatinine, asymmetric and symmetric dimethylarginine (ADMA and SDMA), β2-microglobulin and a large array of protein-bound solutes] by matching 126 maintenance haemodialysis patients subdivided into two age-groups, younger vs. older (using the median as cut-off: 72 years). Concentrations were compared after age stratification and were matched with patient and dialysis characteristics. In addition, 93 non-dialysed CKD patients (median as cut-off: 70 years), with a comparable average estimated glomerular filtration rate (eGFR) between younger and older age-groups, were analysed. In haemodialysis patients, carboxy-methyl-furanpropionic acid (CMPF) levels were markedly higher and BUN and uric acid borderline lower in the older age-group. All other solutes showed no difference. At multifactor analysis, the concentration of several uraemic toxins was associated with residual renal function and protein intake in the overall haemodialysis group and the younger group, but the association with most solutes, especially those protein-bound, was lost in the older age-group. No differences were found in non-dialysed CKD patients. It was concluded that in this CKD population concentrations of uraemic toxins did not change substantially with calendar age.

Entities:  

Keywords:  CKD; Elderly; Haemodialysis; Renal function; Uraemic

Mesh:

Substances:

Year:  2015        PMID: 25857296     DOI: 10.1007/s40620-015-0195-z

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  58 in total

1.  A major inhibitor of phenytoin binding to serum protein in uremia.

Authors:  H Mabuchi; H Nakahashi
Journal:  Nephron       Date:  1988       Impact factor: 2.847

2.  Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease.

Authors:  Sophie Liabeuf; Daniela V Barreto; Fellype C Barreto; Natalie Meert; Griet Glorieux; Eva Schepers; Mohammed Temmar; Gabriel Choukroun; Raymond Vanholder; Ziad A Massy
Journal:  Nephrol Dial Transplant       Date:  2009-11-13       Impact factor: 5.992

3.  p-Cresol and cardiovascular risk in mild-to-moderate kidney disease.

Authors:  Björn K I Meijers; Kathleen Claes; Bert Bammens; Henriette de Loor; Liesbeth Viaene; Kristin Verbeke; Dirk Kuypers; Yves Vanrenterghem; Pieter Evenepoel
Journal:  Clin J Am Soc Nephrol       Date:  2010-04-29       Impact factor: 8.237

4.  Measurement of furancarboxylic acid, a candidate for uremic toxin, in human serum, hair, and sweat, and analysis of pharmacological actions in vitro.

Authors:  T Sassa; H Matsuno; M Niwa; O Kozawa; N Takeda; T Niwa; T Kumada; T Uematsu
Journal:  Arch Toxicol       Date:  2000-02       Impact factor: 5.153

5.  Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxins.

Authors:  Sunny Eloot; Eva Schepers; Daniela V Barreto; Fellype C Barreto; Sophie Liabeuf; Wim Van Biesen; Francis Verbeke; Griet Glorieux; Gabriel Choukroun; Ziad Massy; Raymond Vanholder
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-26       Impact factor: 8.237

6.  Age-related decline in body cell mass in elderly men and women, determined by a noninvasive nuclear technique: effects of physical activity and dietary potassium intake.

Authors:  M Dittmar; H Reber; G Hofmann
Journal:  Am J Hum Biol       Date:  2001 Mar-Apr       Impact factor: 1.937

7.  Furanoid fatty acids from fish lipids.

Authors:  R L Glass; T P Krick; D M Sand; C H Rahn; H Schlenk
Journal:  Lipids       Date:  1975-11       Impact factor: 1.880

Review 8.  The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.

Authors:  Raymond Vanholder; Eva Schepers; Anneleen Pletinck; Evi V Nagler; Griet Glorieux
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

9.  Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis.

Authors:  Riccardo Maria Fagugli; Rita De Smet; Umberto Buoncristiani; Norbert Lameire; Raymond Vanholder
Journal:  Am J Kidney Dis       Date:  2002-08       Impact factor: 8.860

10.  Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.

Authors:  Fellype C Barreto; Daniela V Barreto; Sophie Liabeuf; Natalie Meert; Griet Glorieux; Mohammed Temmar; Gabriel Choukroun; Raymond Vanholder; Ziad A Massy
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-20       Impact factor: 8.237

View more
  5 in total

1.  Long term variation of serum levels of uremic toxins in patients treated by post-dilution high volume on-line hemodiafiltration in comparison to standard low-flux bicarbonate dialysis: results from the REDERT study.

Authors:  Vincenzo Panichi; Maria Teresa Rocchetti; Alessia Scatena; Alberto Rosati; Massimiliano Migliori; Francesco Pizzarelli; Loreto Gesualdo
Journal:  J Nephrol       Date:  2017-03-24       Impact factor: 3.902

2.  Is 3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) a Clinically Relevant Uremic Toxin in Haemodialysis Patients?

Authors:  Mathilde Luce; Anais Bouchara; Myriam Pastural; Samuel Granjon; Jean Christophe Szelag; Maurice Laville; Walid Arkouche; Denis Fouque; Christophe O Soulage; Laetitia Koppe
Journal:  Toxins (Basel)       Date:  2018-05-18       Impact factor: 4.546

Review 3.  Immune Dysfunction in Uremia 2020.

Authors:  Gerald Cohen
Journal:  Toxins (Basel)       Date:  2020-07-05       Impact factor: 4.546

4.  Serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid is associated with lipid profiles and might protect against non-alcoholic fatty liver disease in Chinese individuals.

Authors:  Jiarong Dai; Jufen Yi; Shan Zhang; Peihong Chen; Hua Jin; Xuemei Yu; Xueli Zhang
Journal:  J Diabetes Investig       Date:  2018-11-28       Impact factor: 4.232

5.  Association between Uremic Toxin Concentrations and Bone Mineral Density after Kidney Transplantation.

Authors:  Benjamin Batteux; Sandra Bodeau; Camille André; Anne-Sophie Hurtel-Lemaire; Valérie Gras-Champel; Isabelle Desailly-Henry; Kamel Masmoudi; Youssef Bennis; Ziad A Massy; Saïd Kamel; Gabriel Choukroun; Sophie Liabeuf
Journal:  Toxins (Basel)       Date:  2020-11-13       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.